Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Q3 2023
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData
Out of the top 20 companies, nine saw their market capitalisation surge by more than 10 per cent, with significant gains achieved…